Striving for decreased post-transplant hepatocellular carcinoma recurrence without excluding potentially curable patients: the utility of tumor biology. Editorial Article
Overview
publication date
- October 1, 2019
published in
Identity
PubMed Central ID
- PMC6791992
Digital Object Identifier (DOI)
- 10.21037/hbsn.2019.04.09
PubMed ID
- 31673552
Additional Document Info
volume
- 8
issue
- 5